The emerging role of microbiota derived SCFAs in neurodegenerative disorders
Brain, Behavior, & Immunity - Health · 2025-07 · 46 · 101012
DOI: 10.1016/j.bbih.2025.101012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain, Behavior, & Immunity - Health, 2025-07. Verfasst von Samuel Wachamo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, University of Virginia, Charlottesville, VA, USA. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH National Institute of General Medical Sciences, National Institutes of Health, Owens Family Foundation.
Abstract (Originalsprache)
The microbiota-gut-brain axis (MGBA), the bidirectional communication network between the gastrointestinal tract and the central nervous system, plays a significant role in the pathophysiology of neurodegenerative disorders. Emerging research highlights how gut microbiota dysbiosis, or an imbalance in the microbial community, is linked to the etiology and pathology of these conditions. Microbiota dysbiosis leads to changes in the production of microbial metabolites, such as short-chain fatty acids (SCFAs), which can cross the intestinal barrier and influence the brain either directly or indirectly. Understanding the mechanisms by which dysfunction in the MGBA contributes to neurodegeneration opens potential avenues for novel therapeutic strategies, including microbiota-targeted interventions. This review introduces the MGBA, discusses the role of SCFAs within the MGBA in the context of neurodegenerative disorders, and suggests future research directions.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neuroscience, University of Virginia, Charlottesville, VA, USA.
- Neuroscience Graduate Program, University of Virginia, Charlottesville, VA, USA.
- Center for Brain Immunology and Glia, University of Virginia, Charlottesville, VA, USA.
- Medical Scientist Training Program, School of Medicine, University of Virginia, Charlottesville, VA, USA.
Förderung
- NIH National Institute of General Medical Sciences
- National Institutes of Health
- Owens Family Foundation
- University of Virginia
- National Institute of Allergy and Infectious Diseases Division of Intramural Research
Zitieren
APA
Wachamo, S., & Gaultier, A. (2025). The emerging role of microbiota derived SCFAs in neurodegenerative disorders. Brain, Behavior, & Immunity - Health, 46, 101012. https://doi.org/10.1016/j.bbih.2025.101012
Vancouver
Wachamo S, Gaultier A. The emerging role of microbiota derived SCFAs in neurodegenerative disorders. Brain, Behavior, & Immunity - Health. 2025;46:101012. doi:10.1016/j.bbih.2025.101012
BibTeX
@article{Wachamo2025,
author = {Wachamo, Samuel and Gaultier, Alban},
title = {The emerging role of microbiota derived SCFAs in neurodegenerative disorders},
journal = {Brain, Behavior, & Immunity - Health},
year = {2025},
volume = {46},
pages = {101012},
doi = {10.1016/j.bbih.2025.101012}
}
EUVIMED